What does Radiant Innovation Inc. do?

Radiant Innovation Inc. (3373.TWO) operates in the Medical - Devices industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 3373.TWO's market cap?

Radiant Innovation Inc. (3373.TWO) has a market capitalization of approximately $790.5 million, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 3373.TWO pay a dividend?

Yes — Radiant Innovation Inc. (3373.TWO) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

Is 3373.TWO profitable?

Radiant Innovation Inc. (3373.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

3373.TWO

Radiant Innovation Inc.

TWO·Medical, Devices · Healthcare

NT$16.60NT$0.00+0.00%

Market capNT$790.47M·Aug 26 5:30 AM UTC

Price Chart

NT$16.60+NT$0.00 (+0.00%)today

−59.56%CAGR −16.57%

Select date range

FromTo

Dec 31, 2007Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.00%

Annual Dividend (FWD)NT$0.00

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent DividendNT$0.909

Ex-Dividend DateJul 1

Payment DateJul 29

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateFeb 26

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$409.16M

Net Income−NT$35.23M

Net Margin−8.6%

Operating Cash FlowNT$5.18M

Capital ExpendituresNT$18.64M

Free Cash FlowNT$23.82M

Return on Equity−4.5%

Return on Invested Capital−0.8%

Net CashNT$116.47M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 3373.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 3373.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 3373.TWO and 80,000+ other tickers.

About Radiant Innovation Inc.

Radiant Innovation Inc., a Taiwan-based enterprise, specializes in the creation and advancement of infrared technology solutions. Their product range includes a variety of medical infrared thermometers, specifically non-contact forehead, ear, and multi-functional types, alongside compatible probe covers. Additionally, they offer industrial infrared thermometers and CO2 monitoring devices. The company was established in 1989 and operates primarily from its headquarters situated in Hsinchu City, Taiwan.

CEO: Youqian Huang
Sector: Healthcare
Industry: Medical - Devices
Exchange: TWO
Employees: 300
Website: www.radiantek.com.tw

Peers

Peers Tab

4198.TWO

S&S Healthcare Holding Ltd.

General Biologicals Corporation

Cap

NT$650.5M

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 3373.TWO

What does Radiant Innovation Inc. do?: Radiant Innovation Inc. (3373.TWO) operates in the Medical - Devices industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 3373.TWO's market cap?: Radiant Innovation Inc. (3373.TWO) has a market capitalization of approximately $790.5 million, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 3373.TWO pay a dividend?: Yes — Radiant Innovation Inc. (3373.TWO) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.
Is 3373.TWO profitable?: Radiant Innovation Inc. (3373.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.